Despite their potential to potentiate SDF-1 and thereby exacerbate the vascular complications of type 2 diabetes, DPP-4 inhibitors have emerged as a popular choice for the treatment of the disease because of their ease of use, tolerability and ability to produce predictable and sustained lowering of blood glucose
Luthi et al., however, did not examine treatment duration as a factor, limiting direct comparisons [23]
* Correspondence: Jana Ruda-Kucerova, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
FAQs Why is it important to gradually stop taking GLP-1 medications instead of quitting suddenly
Once this store has been depleted, however, deficiency symptoms slowly set in